To identify key genes and pathways required for survival of cancer cells with activated MYC, we carried out an shRNA genome wide drop-out screen in cancer cell lines with or without expression of MYCN. Using this method, we identified hundreds of shRNAs depleted in MYCN-expressing cells that mainly inactivate genes involved in transcription, cell cycle, and apoptosis. The gene discussed is MYCN; the disease is cancer.